The Global Hidradenitis Suppurativa Treatment Industry is poised for significant growth, with projections indicating a remarkable surge towards a US$1.24 billion valuation by 2033. This significant growth trajectory is fueled by a robust Compound Annual Growth Rate (CAGR) of 4.97% anticipated throughout the forecast period. In 2023, the market is expected to reach US$763.6 million, …